João Incio - Concepedia

Author

João Incio

Massachusetts General Hospital ORCID

Also Known As

J Incio, J. Incio, Joao Incio, João Incio

Publications

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Harvard University Massachusetts Institute of Technology i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto Hospital de São João

About

João Incio is an author at Massachusetts General Hospital specializing in cell biology, medicine, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	671
2	Cell Biology	5	5	671
3	Immunology	2	2	369
4	Engineering	1	1	420
5	Cellular Physiology	1	1	14

João Incio

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy João Incio, Hao Liu, Priya Suboj, Cancer Discovery	2016	453
Solid stress and elastic energy as measures of tumour mechanopathology Hadi T. Nia, Hao Liu, Giorgio Seano, Nature Biomedical Engineering MechanobiologyNonlinear ElasticitySolid StressEngineeringElasticity (Physics)	2016	420
BIM Expression in Treatment-Naïve Cancers Predicts Responsiveness to Kinase Inhibitors Anthony C. Faber, Ryan B. Corcoran, Hiromichi Ebi, Cancer Discovery Selective Kinase InhibitorsCancer BiologyTumor BiologyOncologyBim Levels	2011	274
Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases Nuh N. Rahbari, Dmitriy Kedrin, João Incio, Science Translational Medicine	2016	242
Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2 João Incio, Jennifer A. Ligibel, Daniel T. McManus, Science Translational Medicine Breast OncologyImmunologyPathologyTumor BiologyObesity Prevention	2018	210
Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy Keehoon Jung, Takahiro Heishi, Omar F. Khan, Journal of Clinical Investigation ImmunologyImmunoeditingCurrent Anti-vegf TherapiesDrive ImmunosuppressionImmunotherapy	2017	159
Combined targeting of HER2 and VEGFR2 for effective treatment of<i>HER2</i>-amplified breast cancer brain metastases David P. Kodack, Euiheon Chung, Hiroshi Yamashita, Proceedings of the National Academy of Sciences	2012	152
Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages João Incio, Priya Suboj, Shan M. Chin, PLoS ONE	2015	139
PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity João Incio, Josh Tam, Nuh N. Rahbari, Clinical Cancer Research	2016	132
Targeting CXCR4-dependent immunosuppressive Ly6C <sup>low</sup> monocytes improves antiangiogenic therapy in colorectal cancer Keehoon Jung, Takahiro Heishi, João Incio, Proceedings of the National Academy of Sciences	2017	131

Page 1